119th Congress · introduced in the House · Jul 16, 2025
Patient Access to Innovative New Technologies Act of 2025
Official title from Congress.gov
Latest action (Jul 16, 2025): Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
11 citations.
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: VANTIVE US HEALTHCARE LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$440,000
Spent on own lobbying
Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring. H.R. 4441 - Patient Access to Innovative New Technologies Act, Issues related to sepsis device breakthrough designation.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: THE NICKLES GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
Issues involving NTAP payment for breakthrough technologies, including H.R. 4441, Patient Access to Innovative New Technologies Act of 2025. Home dialysis payment issues, including remote patient monitoring. H.R. 8319, KIDNEY Remote Monitor…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: VANTIVE US HEALTHCARE LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$390,000
Spent on own lobbying
Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring. H.R. 4441 - Patient Access to Innovative New Technologies Act, Issues related to sepsis device breakthrough designation.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: THE NICKLES GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
Issues involving NTAP payment for breakthrough technologies, including H.R. 4441, Patient Access to Innovative New Technologies Act of 2025. Home dialysis payment issues, including remote patient monitoring. H.R. 8319, KIDNEY Remote Monitor…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: THE NICKLES GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
Issues involving NTAP payment for breakthrough technologies, including H.R. 4441, Patient Access to Innovative New Technologies Act of 2025. Home dialysis payment issues, including remote patient monitoring. Issues concerning dialysis.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: VANTIVE US HEALTHCARE LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Medicare/Medicaid
$550,000
Spent on own lobbying
…ESRD reimbursement Issues related to physician reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: THE NICKLES GROUP, LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
Issues involving NTAP payment for breakthrough technologies, including H.R. 4441, Patient Access to Innovative New Technologies Act of 2025. Issues concerning remote patient monitoring for dialysis patients. Issues concerning dialysis.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: VANTIVE US HEALTHCARE LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 16, 2026 · issue area: Medicare/Medicaid
$730,000
Spent on own lobbying
…ESRD reimbursement Issues related to physician reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: VANTIVE US HEALTHCARE LLC
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Medicare/Medicaid
$590,000
Spent on own lobbying
…ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: THE NICKLES GROUP, LLC
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Medicare/Medicaid
$60,000
Paid to lobbying firm
Issues involving NTAP payment for breakthrough technologies, including H.R. 4441, Patient Access to Innovative New Technologies Act of 2025. Issues concerning remote patient monitoring for dialysis patients. Issues concerning dialysis.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VANTIVE US HEALTHCARE LLC · lobbying firm or registrant: VANTIVE US HEALTHCARE LLC
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Medicare/Medicaid
$450,000
Spent on own lobbying
…ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing